Clinical Trials Logo
  1. Home
  2. Electroconvulsive Therapy
  3. NCT02394847

Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose ?

Electroconvulsive Therapy Clinical Trial

Official title:
Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose?

Clinical Trial Summary

Electroconvulsive therapy has been used for many years for different types of physiatric diseases. General anesthesia is used during the procedure. Different anesthesiologists use different regimens. The duration of seizure is important in this procedure. The investigators evaluated the relationship between the dose of propofol and the number of electroconvulsive therapy and duration of the seizure.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02394847
Study type Interventional
Source Ankara University
Contact
Status Completed
Phase N/A
Start date January 2012
Completion date December 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT01876758 - Cognitive Training for Memory Deficits Associated With Electroconvulsive Therapy N/A
Completed NCT04348825 - Electroconvulsive Therapy and Neuroradiology
Enrolling by invitation NCT05515159 - Blood Biomarkers in Electroconvulsive Therapy
Completed NCT04022226 - EEG Characteristics in ECT Early Phase 1
Recruiting NCT05889234 - Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
Recruiting NCT04291196 - Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT N/A
Recruiting NCT04160286 - The Danish Neuropsychological Study of the Adverse Effects of ECT
Terminated NCT04383509 - Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Completed NCT05683028 - RCT for Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Completed NCT05633368 - Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy
Completed NCT03359395 - Pre-medication With Alfentanil vs Placebo During ECT Phase 4
Recruiting NCT05900245 - Anesthesia Induction Schemes of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring N/A
Recruiting NCT03542903 - ECT in Ultra-resistant Schizophrenia N/A
Completed NCT02819375 - Comparison of Propofol, Propofol-remifentanil and Propofol-ketamine Anesthesia During Electroconvulsive Therapy Phase 4
Not yet recruiting NCT02305394 - Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy Phase 4
Recruiting NCT06109480 - Effect of HD-tDCS Assisted ECT for Depression Disorder N/A
Completed NCT05408000 - Comparision of Motor Seizure Duration of Ketofol and Propofol for Electroconvulsive Therapy N/A
Completed NCT01870219 - Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy Phase 4
Completed NCT04028596 - Measuring Blood Flow in the Brain After Epileptic Activity Phase 2
Completed NCT03113968 - ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) Phase 2/Phase 3